Yunjian Pan

4PUBLICATIONS
14CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Dec 17, 2024
Tislelizumab combined with nab-paclitaxel and cisplatin as the more effective chemoimmunotherapy strategy in the neoadjuvant treatment of locally advanced thoracic esophageal squamous cell carcinoma: A prospective, two-cohort, phase 2 trial.

Jie Wang, Bin Li, Yawei Zhang

|Feb 28, 2023
RBM10 Loss Promotes EGFR-Driven Lung Cancer and Confers Sensitivity to Spliceosome Inhibition.

Yufang Bao, Sirui Zhang, Xiaoyu Zhang

|Mar 07, 2019
tRNA-based prognostic score in predicting survival outcomes of lung adenocarcinomas.

Muyu Kuang, Difan Zheng, Xiaoting Tao

|Sep 20, 2018
Frequency and clinical significance of NF1 mutation in lung adenocarcinomas from East Asian patients.

Yunjian Pan, Chongze Yuan, Chao Cheng

Pageof 1

Frequent Collaborators

3 joint publications

Shanbo Zheng

2 joint publications

Haiquan Chen

1 joint publications

Muyu Kuang

1 joint publications

Yufang Bao